YBX1 as a prognostic biomarker and potential therapeutic target in hepatocellular carcinoma: A comprehensive investigation through bioinformatics analysis and in vitro study

Abstract YBX1 is highly expressed in pan-cancer and is associated with poor prognosis in many tumors, suggesting its potential as a prognostic marker for cancers. YBX1 significantly impacts the infiltration of immune cells in the tumor microenvironment. YBX1 might be involved in regulating tumor lipid metabolism, further affecting tumor growth. YBX1 can serve as a key therapeutic target for anti-tumor treatments, with targeting YBX1 effectively inhibiting the growth and proliferation of liver cancer cells. Article type: Research Article Keywords: YBX1,